ChemCon has received approval, following a successful inspection by the German health authorities in July 2013, to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use.   ChemCon will now offer services that include the early R&D stages of drug development, the transfer of the manufacturing process to production under GMP conditions, and the production of drug product samples for clinical trials for both placebo and active treatment arms.   The company r...